FOI Request
- Disclosure ID
- FOI/02885
- Request Date
- January 2, 2019
- Subject
- Biologic Therapy
- Description
1. How many patients have been diagnosed with Psoriatic arthritis in the last 12 months and how many in each hospital within the trust
2. If known how many of these patients are newly diagnosed
3. How many of the patients with Psoriatic arthritis patients are treated with biologic therapy (disease modifying therapy) to include numbers for:
• adalimumab
• apremilast
• certolizumab
• etanercept
• golimumab
• infliximab
• secukinumab
• ustekinumab
• ixekizumab
• tofacitinib4. Are clinics held specifically for Psoriatic Arthritis, if so, how many and at which hospitals within the trust?
5. How many patients have been diagnosed with Ankylosing spondyltiis in the last 12 months and how many in each hospital within the trust?
6. If known how many of these patients are newly diagnosed
7. How many of the patients with Ankylosing Spondylitis arthritis are treated with biologic therapy (disease modifying therapy) to include numbers for:
• Etanercept
• Infliximab
• Adalimumab
• Golimumab
• Certolizumab
• Secukinumab8. Are clinics held specifically for Ankylosing spondyltiis if so how many and at which hospitals
- Response
1. How many patients have been diagnosed with Psoriatic arthritis in the last 12 months and how many in each hospital within the trust We can confirm we do not hold this information. 2. If known how many of these patients are newly diagnosed N/A 3. How many of the patients with Psoriatic arthritis patients are treated with biologic therapy (disease modifying therapy) to include numbers for: • adalimumab
• apremilast
• certolizumab
• etanercept
• golimumab
• infliximab
• secukinumab
• ustekinumab
• ixekizumab
• tofacitinib
This data is not readily available and would require a manual trawl through paper records which would constitute a disproportionate effort to retrieve and would exceed 18 hours. This information is therefore exempt on the grounds of cost (Section 12(1)). 4. Are clinics held specifically for Psoriatic Arthritis, if so, how many and at which hospitals within the trust? No 5. How many patients have been diagnosed with Ankylosing spondyltiis in the last 12 months and how many in each hospital within the trust? We can confirm we do not hold this information. 6. If known how many of these patients are newly diagnosed We can confirm we do not hold this information. 7. How many of the patients with Ankylosing Spondylitis arthritis are treated with biologic therapy (disease modifying therapy) to include numbers for: • Etanercept
• Infliximab
• Adalimumab
• Golimumab
• Certolizumab
• Secukinumab
This data is not readily available and would require a manual trawl through paper records which would constitute a disproportionate effort to retrieve and would exceed 18 hours. This information is therefore exempt on the grounds of cost (Section 12(1)). 8. Are clinics held specifically for Ankylosing spondylitis if so how many and at which hospitals Yes (physiotherapist-led). Fortnightly clinics held at Blackpool Victoria Hospital, Clifton Hospital and Fleetwood Hospital.